DMMA
 
1-(3,4-Dimethoxyphenyl)-N-methylpropan-2-amine
 6620 ·  C12H19NO2 ·  209.285
 InChI=1S/C12H19NO2/c1-9(13-2)7-10-5-6-11(14-3)12(8-10)15-4/h5-6,8-9,13H,7H2,1-4H3
 BUWHCARWGYFQPE-UHFFFAOYSA-N This stereoisomer Any stereoisomer
 CNC(Cc1ccc(c(c1)OC)OC)C

Felim, A; Herrera, G; Neudõrffer, A; Blanco, M; O’Connor, J; Largeron, M. Synthesis and in vitro cytotoxicity profile of the R-enantiomer of 3,4-dihydroxymethamphetamine (R-(-)-HHMA): Comparison with related catecholamines. Chem. Res. Toxicol., 2010, 23 (1), 211–219. 349 kB. https://doi.org/10.1021/tx9003374

Clark, CC. The identification of methoxy-N-methylamphetamines. J. Forensic Sci., 1 Oct 1984, 29 (4), 1056–1071. 423 kB. https://doi.org/10.1520/JFS11772J

EMCDDA. New drugs in Europe, 2011, European Monitoring Centre for Drugs and Drug Addiction, 1 Apr 2012. 401 kB.

Milhazes, N; Cunha-Oliveira, T; Martins, P; Garrido, J; Oliveira, C; Rego, AC; Borges, F. Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine (“Ecstasy”) and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship. Chem. Res. Toxicol., 2006, 19 (10), 1294–2304. 204 kB. https://doi.org/10.1021/tx060123i #17

2C-E
2C-G
DOM
ψ-DOM
2,5-DMMA · METHYL-DMA
4C-DMA · 4C-H
4C-DMPEA
N-Me-2C-D
2C-D-2-EtO · 2CD-2ETO
2C-D-5-EtO · 2CD-5ETO
m-DOM · 5-DOM
o-DOM · 2-DOM
6-Me-2,4-DOM · Z-7.1
2,4-DMMA
ψ-2C-E
4-Propoxynorephedrine
homo-DMA
homo-N-Me-2,5-DMPEA
BO3MDM
BO3MEA
BO3EE
BO3P
N,N-Me-DMPEA-2
N-Me-2,3-DMA
N-Me-2,3-EMPEA
4C-2,4-DMPEA
2,4-DEPEA
N-Me,N-iPr-DHPEA
N-Bu-DHPEA
N-iBu-DHPEA
MHEA
N-Me-α-Et-GEA
Salicifoline
HMEA
N,N-Me-DMPEA
N-Et-DMPEA
N-Me-EMPEA
EMA
MEA
DEPEA
β-HO-N-Me-2-M-5-MeA
N,N-Me-2,5-HMA
N,N-Me-2C-H
β,N-Me-2,5-DMPEA
N,N-Me-3,5-DMPEA
N-Me-3,5-DMA
N,N-Me-2,6-DMPEA
N-Me-2,6-DMA
4-Me-2,3-DOM
3-Me-2,4-DOM
2-Me-3,4-DOM
5-Me-2,3-DOM
3-DOM
2-Me-3,5-DOM
BMD
5-Me-3,4-DOM
4-Me-3,5-DOM
6-Me-2,3-DOM
3-Me-2,6-DOM
2-Me-3,6-DOM
6-Me-2,4-EMPEA
2C-H-2-iPrO
10432
10408
DE
10096
10048
10034
10027
3,5-DMB
2C-H-5-iPrO
16 November 2018 · Creative Commons BY-NC-SA ·